Previous studies have suggested that urine cytology adequacy may be related to both specimen volume and cellularity. METHODS: The authors reviewed cytospin preparations from 314 urine specimens (162 voided and 152 instrumented specimens) found to have high-grade urothelial carcinoma on biopsy. RESULTS: The sensitivity of instrumented urine cytology was significantly higher than that of voided cytology (82% vs 25%; P < .001). The cellularity (at least 30 urothelial cells/10 high-power fields [HPF]) of instrumented urine specimens also was significantly higher than that of voided specimens (57% vs 9%; P < .001). The sensitivity of voided urine cytology with a cellularity of 20 to 39 cells per 10 HPF was significantly higher than that of cases with <20 cells per 10 HPF (77% vs 19%; P < .001). The sensitivity decreased with higher cellularity for both types of specimens. The sensitivity of voided cases with a volume of at least 30 mL was higher than that of cases with a volume <30 mL, but this was not statistically significant (31% vs 17%; P = .07).
INTRODUCTION
To our knowledge, adequacy criteria for urine cytology specimens are not well defined. Previous studies of ThinPrep preparations (Hologic Inc, Marlborough, Massachusetts) of urinary bladder barbotage cytology suggest that specimens with <10 well-preserved, well-visualized urothelial cells per 10 high-power fields (HPF) should be diagnosed as unsatisfactory, and cases with 10 to 20 cells per 10 HPF should be diagnosed as "less than satisfactory." 1 Studies using cytospin preparations of instrumented urine specimens have suggested that cases with <10 urothelial cells as well cases with >50 urothelial cells per 10 HPF have lower sensitivity for highgrade urothelial carcinoma compared with cases with cellularity between these 2 extremes. 2 Other studies also have suggested that specimen volume also may be associated with adequacy in voided urine specimens. 3 To the best of our knowledge, the correlation of urine cytology cellularity with sensitivity in voided urine specimens has not been well studied to date. In the current study, we sought to determine the relationship between the number of urothelial cells in a voided urine specimen and specimen volume with the sensitivity of urine cytology for high-grade urothelial carcinoma and compared this with the performance of instrumented urine specimens.
MATERIALS AND METHODS
We reviewed cytospin preparations from 162 voided urine specimens found to have high-grade urothelial carcinoma on follow-up within 1 year and compared them with 152 instrumented urine cytology specimens with high-grade urothelial carcinoma identified on biopsy at the same time the urine specimen was obtained. The instrumented specimens were a subset of the cases that were reported previously, 2 not all of which had a biopsy performed on the same day as the urine specimen was obtained. The majority of these specimens were likely barbotage specimens, but this was not consistently noted on the requisition form. The designation of a voided specimen required that the submitting physician designate the specimen as voided and that there were no bladder biopsies performed on the patient on that same day. All voided cases had a subsequent biopsy performed within 1 year of the voided specimen. All cases were from Baptist Hospital in Miami, Florida, from 2008 through 2017. All diagnoses were based on the review diagnosis (A.A.R.). For statistical purposes, diagnoses of either "suspicious" or "positive" were considered as positive results; diagnoses of either "benign" or "atypical" were considered to be negative results. Only urothelial cells were included in the cellularity. To measure cellularity, 10 consecutive HPF were viewed and the number of urothelial cells counted.
All urine specimens were processed using cytocentrifugation and stained with Papanicolaou staining and hematoxylin and eosin. For all specimens, 50 mL (or all of the specimen if <50 mL) was centrifuged at 1500 rpm for 10 minutes. The resulting supernatant fluid was poured off, and the remaining sediment resuspended and 1 to 4 drops placed in each chamber of a Shandon Cytospin 4 machine (Richard-Allan Scientific, Kalamazoo, Michigan). One to 2 drops of Saccomanno fluid (Richard-Allan Scientific) was added to each chamber and the specimen spun at 1000 rpm for 3 minutes. The resulting 2 slides were either spray fixed or placed in 95% alcohol.
Breakpoints for cellularity were similar to those previously published, with the exception that cases with <10 urothelial cells per 10 HPF were divided into 2 groups due to the increased number of cases with this cellularity. Specimen volumes were divided to produce groups with an even distribution of cases.
Statistical Analysis
Statistical analysis was performed using a 2-tailed chisquare test with Yates correction and a significance level of P = .05.
RESULTS
The sensitivity of instrumented urine cytology was found to be significantly higher than that of voided cytology (82% vs 25%; P < .001). The cellularity (at least 30 urothelial cells/10 HPF) of instrumented urine specimens also was significantly higher than that of voided specimens (57% vs 9%; P < .001). 
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The sensitivity of voided urine cytology with a cellularity of 20 to 39 cells per 10 HPF was significantly higher than that of cases with <20 cells per 10 HPF (77% vs 19%; P < .001) (Fig. 1) . The sensitivity decreased with higher cellularity for both types of specimens.
The sensitivity of voided cases with a volume of ≥30 mL was higher than that of cases with a volume of <30 mL, but this was not statistically significant (31% vs 17%; P = .07) (Fig. 2) .
DISCUSSION
The results of the current study of voided urine specimens have extended the observations of previous studies, 1, 2 and demonstrated that the number of urothelial cells in a urine specimen is correlated with the sensitivity of that specimen for high-grade urothelial carcinoma. Nevertheless, there are differences between the results of the current study and those of prior studies. Most important, the cellularity of these voided urine specimens was much lower than that of instrumented specimens, and the sensitivity of voided urine for high-grade urothelial carcinoma was correspondingly lower. Nevertheless, the same increase and subsequent decease in sensitivity with increasing cellularity that was reported previously 2 also was identified in voided specimens. Although previous studies have suggested that the sensitivity of urine cytology should approach 79%, 4 this prior study did not clearly distinguish between voided and instrumented urine specimens. Indeed, although the study by Bastacky et al stated that approximately 72% of their specimens were voided or "not otherwise specified," the fact that 79% of the cases of high-grade urothelial carcinoma had a corresponding biopsy taken on the same day strongly suggests that the vast majority of "not otherwise specified" cases were in fact instrumented specimens because the rationale for obtaining a voided urine specimen when the patient is undergoing an invasive procedure for biopsy is not clear. 4 In addition, the overall sensitivity that we reported herein for instrumented urine specimens with biopsy performed at the same time is very similar to that of previous studies. However, the results of the current study suggest that voided urine cytology specimens are unlikely to achieve such a high sensitivity. There are several possible reasons for this difference. First, instrumented urine specimens may simply be a better sample with a higher sensitivity. Conversely, as we have shown, the average cellularity of voided urine specimens is significantly lower than that of instrumented specimens, and this may explain part of the deceased sensitivity that was noted. When voided specimens had an optimal cellularity of 20 to 39 urothelial cells per 10 HPF, the results were similar (although slightly less) to those of instrumented urine specimens. In addition, in the current study, the patients with instrumented specimens had biopsies performed on the same day that the urine specimens were collected. In contrast, the biopsies for patients with voided specimens never were performed on the same day, but instead were obtained up to 1 year Cancer Cytopathology February 2019 after the specimen was collected. As a result, interval cases in which the tumor arose between the time the urine cytology specimen was collected and the biopsy could not be excluded and also may account for at least some of this decreased sensitivity. Finally, the patients who underwent concurrent urine cytology and biopsy presumably did so after a clinical evaluation, which likely increased the pretest probability of finding high-grade urothelial carcinoma at that time. Although this most typically results in a change to the positive and negative predictive values of the test, this process also may affect the apparent sensitivity of the test by selecting for a group of tumors (eg, larger tumors, those more easily shed in urine) that are more likely to be identified by urine cytology.
In all of these studies, cellularity was measured as the number of cells per 10 HPF or density rather than a total number of cells. The area of the slide that is covered with cells with a ThinPrep preparation is much larger than that of a cytospin preparation, even when 2 cytospin preparations are made. As a result, the total number of cells may be quite different even when the density is the same, a situation that may occur when different processes are used or different numbers of slides are made. Nevertheless, the sensitivities reported for cytospin preparations and ThinPrep preparations are similar, suggesting that cell density rather than total cells may be the preferred measure of cellularity in these specimens. Nevertheless, additional studies comparing the total number of cells and cell density with sensitivity for high-grade urothelial carcinoma in preparations with different areas appear warranted.
Previous studies also have suggested that urine volume also may be associated with both the use of the term "nondiagnostic" by cytologists as well as the rate of suspicious or positive cytologic results. 3 However, to the best of our knowledge, in that prior study, 3 the criteria for a "nondiagnostic" result were never defined and the authors never measured the sensitivity of the test. In the current study, we did not find a significant association between the sensitivity of the detection of high-grade urothelial carcinoma and volume. Although the current study data do suggest that there may be a benefit to obtaining at least 30 mL of urine, we were not able to demonstrate a significant difference in the sensitivity of these specimens. As a result, there appears to be little reason to use volume as an adequacy criteria when a highly successful alternative (cell density) exists. Finally, the results of the current study suggest thresholds that might be of value for defining adequacy in urine cytology. For instrumented urine specimens, all specimens should be considered as adequate, because it is unlikely that the invasive procedure necessary for a repeat sample will be repeated based only on the cytologic diagnosis of nondiagnostic. For voided urine specimens, cases with no urothelial cells should be considered inadequate, whereas cases with <20 cells per 10 HPF should be considered as limited because they have a significantly lower sensitivity. A repeat voided specimen may be considered in either case if clinically appropriate.
The sensitivity of voided urine cytology for highgrade urothelial carcinoma is significantly associated with urothelial cellularity but not specimen volume. Both the cellularity and sensitivity of voided urine specimens are less than those of instrumented specimens.
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